Invivyd (IVVD) Enterprise Value (2020 - 2025)
Invivyd posted quarterly Enterprise Value of -$226.7 million for Q4 2025, down 226.88% year-on-year from $178.7 million in Q4 2024, and down 166.8% on a QoQ basis from -$85.0 million in Q3 2025.
Invivyd (IVVD) has 6 years of Enterprise Value data on file, last reported at -$226.7 million in Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value fell 226.88% year-over-year to -$226.7 million; the trailing twelve-month figure through Dec 2025 stood at -$226.7 million (down 226.88% YoY), and the FY2025 full-year result was -$226.7 million, down 226.88% from the prior year.
- Enterprise Value for Q4 2025 stood at -$226.7 million, down from -$85.0 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$34.9 million in Q2 2025 and bottomed at -$542.2 million in Q4 2021.
- The 5-year median for Enterprise Value is -$181.8 million (2023), against an average of -$227.9 million.
- The widest annual swing landed in 2021, when Enterprise Value slumped 371.55%; it then jumped 83.02% in 2022.
- A 5-year view of Enterprise Value shows it stood at -$542.2 million in 2021, then surged by 83.02% to -$92.1 million in 2022, then tumbled by 117.91% to -$200.6 million in 2023, then jumped by 65.44% to -$69.3 million in 2024, then plunged by 226.88% to -$226.7 million in 2025.
- The last three Enterprise Value figures came in at -$226.7 million (Q4 2025), -$85.0 million (Q3 2025), and -$34.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Invivyd | 208.38 Mn | -18.31 Mn | - | -226.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -226.69 Mn |
| Sep 30, 2025 | -84.97 Mn |
| Jun 30, 2025 | -34.91 Mn |
| Mar 31, 2025 | -48.08 Mn |
| Dec 31, 2024 | -69.35 Mn |
| Sep 30, 2024 | -106.87 Mn |
| Jun 30, 2024 | -147.88 Mn |
| Mar 31, 2024 | -189.39 Mn |
| Dec 31, 2023 | -200.64 Mn |
| Sep 30, 2023 | -181.82 Mn |
| Jun 30, 2023 | -121.95 Mn |
| Mar 31, 2023 | -126.47 Mn |
| Dec 31, 2022 | -92.08 Mn |
| Sep 30, 2022 | -278.15 Mn |
| Jun 30, 2022 | -474.89 Mn |
| Mar 31, 2022 | -532.22 Mn |
| Dec 31, 2021 | -542.22 Mn |
| Sep 30, 2021 | -478.27 Mn |
| Jun 30, 2021 | -392.51 Mn |
| Dec 31, 2020 | -114.99 Mn |